Unlocking tumor immune evasion: IL1RL1+ Treg cells and CAFs collaborate for immunotherapy resistance

Researchers demonstrated that the crosstalk between IL1RL1+ regulatory T-cells (Treg) and cancer-associated fibroblasts (CAFs) drives the tissue repairing.

Novel imaging approach accurately identifies sub-types of primary aldosteronism

A novel imaging approach, 68Ga-pentixafor PET/CT, has been shown to accurately identify sub-types of primary aldosteronism (an adrenal gland disorder), outperforming traditional methods for diagnosis.

January 19, 2024

Roche’s PI3K inhibitor secures breakthrough status in breast cancer – Pharmaceutical Technology

The FDA granted Roche’s breast cancer therapy a breakthrough designation. Credit: Jonathan Weiss via Shutterstock. The US Food and Drug Administration (FDA) has granted Roche

May 21, 2024

What Amazon Prime’s new One Medical offering reveals about the future of health care

Amazon Prime members have a new offer in addition to the usual delivery and streaming services: Access to One Medical, the Amazon-owned primary care company.

November 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.